Xuefeng Hu, Ph.D. - Publications
Affiliations: | 2012 | Public Health | The Chinese University of Hong Kong, Hong Kong, Hong Kong |
Area:
Public HealthYear | Citation | Score | |||
---|---|---|---|---|---|
2015 | Mao C, Fu XH, Yuan JQ, Yang ZY, Huang YF, Ye QL, Wu XY, Hu XF, Zhai ZM, Tang JL. Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission. The Cochrane Database of Systematic Reviews. 11: CD010248. PMID 26544114 DOI: 10.1002/14651858.Cd010248.Pub2 | 0.468 | |||
2014 | Yang ZY, Liu L, Mao C, Wu XY, Huang YF, Hu XF, Tang JL. Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer. The Cochrane Database of Systematic Reviews. 11: CD009948. PMID 25400254 DOI: 10.1002/14651858.Cd009948.Pub2 | 0.514 | |||
2012 | Yang ZY, Shen WX, Hu XF, Zheng DY, Wu XY, Huang YF, Chen JZ, Mao C, Tang JL. EGFR gene copy number as a predictive biomarker for the treatment of metastatic colorectal cancer with anti-EGFR monoclonal antibodies: a meta-analysis. Journal of Hematology & Oncology. 5: 52. PMID 22897982 DOI: 10.1186/1756-8722-5-52 | 0.495 | |||
Show low-probability matches. |